BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5778 related articles for article (PubMed ID: 16382989)

  • 1. [The role of intermedial filament nestin in malignant melanoma progression].
    Brychtová S; Fiurásková M; Brychta T; Hirnák J
    Cesk Patol; 2005 Oct; 41(4):143-5. PubMed ID: 16382989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
    J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the neuroectodermal intermediate filament nestin in human melanomas.
    Flørenes VA; Holm R; Myklebost O; Lendahl U; Fodstad O
    Cancer Res; 1994 Jan; 54(2):354-6. PubMed ID: 8275467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of stem cell markers in malignant melanoma.
    Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
    Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
    Chen PL; Chen WS; Li J; Lind AC; Lu D
    Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
    Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
    Oncol Rep; 2013 Apr; 29(4):1595-9. PubMed ID: 23417116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
    Mihic-Probst D; Kuster A; Kilgus S; Bode-Lesniewska B; Ingold-Heppner B; Leung C; Storz M; Seifert B; Marino S; Schraml P; Dummer R; Moch H
    Int J Cancer; 2007 Oct; 121(8):1764-70. PubMed ID: 17597110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours.
    Ehrmann J; Kolár Z; Mokry J
    J Clin Pathol; 2005 Feb; 58(2):222-3. PubMed ID: 15677549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP; Smart C; Cassarino DS
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
    Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
    Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi.
    Prieto VG; McNutt NS; Lugo J; Reed JA
    Am J Surg Pathol; 1997 Dec; 21(12):1450-4. PubMed ID: 9414188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
    Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
    Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
    Bröcker EB; Magiera H; Herlyn M
    J Invest Dermatol; 1991 May; 96(5):662-5. PubMed ID: 1850772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW
    J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nestin is expressed in HMB-45 negative melanoma cells in dermal parts of nodular melanoma.
    Kanoh M; Amoh Y; Tanabe K; Maejima H; Takasu H; Katsuoka K
    J Dermatol; 2010 Jun; 37(6):505-11. PubMed ID: 20536663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 289.